The purpose of this study is to evaluate food effect on the pharmacokinetics of NVP-1203

This study is designed as randomized, open-label, crossover assignment for evaluate the food effect on the pharmacokinetics of NVP-1203 in healthy adult subjects

Inclusion Criteria:

• healthy adult subjects who signed informed consent

Exclusion Criteria:

• Subjects has a history of allergy reaction of study drug ingredient
• Subjects participated in another clinical trial within 3 months prior to administration of the study drug
• Inadequate subject for the clinical trial by the investigator's decision